Overview
- Deputy Chief Minister Rajendra Shukla said 20 children have died in Madhya Pradesh (17 in Chhindwara, two in Betul, one in Pandhurna) with five more under treatment in Nagpur.
- WHO asked India whether the implicated Coldrif syrup was exported and said it will assess issuing a Global Medical Products Alert once it receives official confirmation.
- States including Tamil Nadu, Madhya Pradesh, Kerala, Karnataka, Punjab, Himachal Pradesh, Uttar Pradesh, Puducherry and Maharashtra restricted or banned Coldrif; Gujarat and other regulators flagged Relife and Respifresh TR for DEG above limits.
- Tamil Nadu’s drug control issued a show‑cause notice to Sresan Pharmaceuticals, cited hundreds of GMP lapses, confirmed adulteration, halted production, and police teams moved to Kancheepuram to pursue the company owner.
- The Union Health Ministry reported 19 samples collected with 10 detailed results so far (nine compliant, one failing) and launched risk‑based inspections; Madhya Pradesh formed an SIT, suspended officials, and arrested a prescribing doctor as the IMA objected to his detention.